mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.081 |
0.06 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.06 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |